| KoecaneDope vs King | 13–17 | 43.33% |
| KoecaneDope vs Reina | 11–10 | 52.38% |
| KoecaneDope vs Steve | 14–6 | 70.00% |
| KoecaneDope vs Lidia | 8–12 | 40.00% |
| KoecaneDope vs Law | 7–11 | 38.89% |
| KoecaneDope vs Yoshimitsu | 7–8 | 46.67% |
| KoecaneDope vs Victor | 6–9 | 40.00% |
| KoecaneDope vs Jin | 7–6 | 53.85% |
| KoecaneDope vs Asuka | 6–7 | 46.15% |
| KoecaneDope vs Nina | 8–4 | 66.67% |
| KoecaneDope vs Kazuya | 1–10 | 9.09% |
| KoecaneDope vs Dragunov | 2–9 | 18.18% |
| KoecaneDope vs Lars | 1–10 | 9.09% |
| KoecaneDope vs Claudio | 3–7 | 30.00% |
| KoecaneDope vs Hwoarang | 4–5 | 44.44% |
| KoecaneDope vs Leroy | 1–8 | 11.11% |
| KoecaneDope vs Xiaoyu | 2–6 | 25.00% |
| KoecaneDope vs Bryan | 1–7 | 12.50% |
| KoecaneDope vs Devil Jin | 3–5 | 37.50% |
| KoecaneDope vs Jun | 3–5 | 37.50% |
| KoecaneDope vs Eddy | 5–3 | 62.50% |
| KoecaneDope vs Paul | 3–4 | 42.86% |
| KoecaneDope vs Feng | 3–4 | 42.86% |
| KoecaneDope vs Lili | 4–3 | 57.14% |
| KoecaneDope vs Alisa | 3–4 | 42.86% |
| KoecaneDope vs Lee | 1–5 | 16.67% |
| KoecaneDope vs Panda | 5–1 | 83.33% |
| KoecaneDope vs Shaheen | 4–1 | 80.00% |
| KoecaneDope vs Azucena | 1–4 | 20.00% |
| KoecaneDope vs Kuma | 0–4 | 0.00% |
| KoecaneDope vs Jack-8 | 1–1 | 50.00% |
| KoecaneDope vs Leo | 0–2 | 0.00% |
| KoecaneDope vs Raven | 0–2 | 0.00% |
| KoecaneDope vs Zafina | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.